Statera Biopharma, Inc. Annual Operating Income (Loss) in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Statera Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2021.
  • Statera Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$1.55M, a 84% increase year-over-year.
  • Statera Biopharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$88.2M, a 261% decline year-over-year.
  • Statera Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$98.3M, a 836% decline from 2020.
  • Statera Biopharma, Inc. annual Operating Income (Loss) for 2020 was -$10.5M, a 345% decline from 2019.
  • Statera Biopharma, Inc. annual Operating Income (Loss) for 2019 was -$2.36M, a 50.8% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$98.3M -$87.8M -836% Jan 1, 2021 Dec 31, 2021 10-K 2022-10-06
2020 -$10.5M -$8.14M -345% Jan 1, 2020 Dec 31, 2020 10-K 2022-10-06
2019 -$2.36M +$2.44M +50.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 -$4.8M +$801K +14.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-15
2017 -$5.6M +$755K +11.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$6.36M +$4.44M +41.1% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-06
2015 -$10.8M +$3.63M +25.2% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-22
2014 -$14.4M +$8.65M +37.5% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-23
2013 -$23.1M +$6.97M +23.2% Jan 1, 2013 Dec 31, 2013 10-K 2015-02-27
2012 -$30M -$4.94M -19.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 -$25.1M -$14.4M -134% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 -$10.7M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.